SMASR and lung carcinoma: Importantly, SMASR inhibits the TGFβRI by interacting with Smad2/3, leading to the inactivation of the TGFβ/SMAD signaling pathway and forming a negative feedback loop, which plays a critical role in regulating EMT in lung cancer.